Shares of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) are currently up 7% at $7.96 per share during Wednesday afternoon trading. Today's trading range for shares of Vanda Pharmaceuticals Inc has been between $7.50 and $8.00 per share. The...(
read more)
Hapoalim Securities is out with a research report this morning, where it reiterates its Buy rating on Vanda Pharmaceuticals (NASDAQ: VNDA); it has a $15.00 price target on the stock.
The HS analysts noted that Fanapt is catching up...(
read more)
Avnet, Inc. (AVT) recently announced that it has acquired a controlling interest in Vanda Group from Hutchinson Whampoa Limited in a strategic move to expand its presence and customer base across...(
read more)